HEAL Study
Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement
Short Description
To evaluate the degree to which a combined group and individual 12-Step facilitative intervention, Stimulant Abuser Groups to Engage in 12-Step (STAGE-12), improves substance-related outcomes compared to treatment as usual (TAU) without STAGE-12 among stimulant abusers.
Release Date
Feb 06, 2012

This was a randomized, controlled clinical trial in which 471 stimulant abusers were recruited from 10 sites to participate in study comparing 12-Step (STAGE-12) plus treatment as usual (TAU) to TAU alone. The purpose of this study was to evaluate reduction in percent of days of stimulant use as measured by self-report. The study also evaluated reduction in percent days of use of other substances, the degree to which STAGE-12 increased involvement in 12-step activities and attendance at 12-step meetings, and the extent to which such 12-step involvement and meeting attendance mediated substance use outcomes.

Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Data
Study Links
Study Documents